CHARM

Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative)

Stadium: klaar
Middel: candesartan
Populatie: Hartfalen
Fase: III
First Patient In: -
Last Patient In: -
Last Patient Last Visit: -

Studiedirecteur

prof. dr. J.H. Cornel

Cardioloog